Glaxo Research Center Opened in Canada
The Glaxo Heritage Research Institute, located at the University of Alberta, Canada, was opened recently by the Alberta Premier Ralph Kline. Glaxo has contributed C$5 million ($3.6 million) towards the project, and the Alberta Heritage Foundation for Medical Research has pledged C$1.8 million over a five-year period.
Glaxo has pledged a further C$2.6 million over the next three years. At the opening ceremony, Glaxo Canada president Paul Lucas said that the firm is considering additional research collaboration with the Institute.
Following the merger of Glaxo with Wellcome (Marketletters passim), there has been speculation in the local press in Canada on how the merger will affect the two Canadian units. A spokesperson at Glaxo Wellcome Canada is reported to have said that there will be some reductions but would not be specific.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze